{"id":3729,"date":"2023-04-14T13:43:34","date_gmt":"2023-04-14T13:43:34","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=3729"},"modified":"2023-04-14T13:43:36","modified_gmt":"2023-04-14T13:43:36","slug":"geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/","title":{"rendered":"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies."},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-112.png\" alt=\"\" class=\"wp-image-3731\" width=\"152\" height=\"152\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-112.png 200w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-112-150x150.png 150w\" sizes=\"(max-width: 152px) 100vw, 152px\" \/><\/figure>\n\n\n\n<p>Plymouth Meeting, PA &#8211; <a href=\"https:\/\/www.geneostx.com\/\">Geneos Therapeutics<\/a>, a leading biotechnology research company focused on developing personalized immunotherapies for cancer treatment, announced today the successful completion of its Series A funding round. The company has raised $5 million in funding from <a href=\"https:\/\/3bfuturehealth.com\/\">3B Future Health Fund I &amp; II<\/a>, a venture capital and private equity principal.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"491\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-113-1024x491.png\" alt=\"\" class=\"wp-image-3732\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-113-1024x491.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-113-300x144.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-113-768x368.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-113.png 1136w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Geneos Therapeutics, co-founded by Niranjan Sardesai, is headquartered in Plymouth Meeting, PA, and is committed to harnessing the power of the body&#8217;s own immune system to fight cancer. Geneos&#8217; GT-EPIC platform is a breakthrough technology that identifies and targets neoantigens, which are unique proteins found on the surface of cancer cells. By leveraging these neoantigens, Geneos can develop personalized immunotherapies that specifically target and destroy cancer cells, while minimizing harm to healthy cells.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"608\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-114-1024x608.png\" alt=\"\" class=\"wp-image-3733\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-114-1024x608.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-114-300x178.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-114-768x456.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-114.png 1448w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>&#8220;We are thrilled to receive this funding from 3B Future Health Fund I &amp; II, which will enable us to accelerate the development of our GT-EPIC platform and advance our personalized immunotherapies to clinical trials,&#8221; said <a href=\"https:\/\/www.linkedin.com\/in\/niranjan-sardesai-7645131\/\">Niranjan Sardesai<\/a>, co-founder of Geneos Therapeutics. &#8220;This funding will also help us expand our team and infrastructure to support the growing demand for personalized cancer immunotherapies.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Plymouth Meeting, PA &#8211; Geneos Therapeutics, a leading biotechnology research company focused on developing personalized immunotherapies for cancer treatment, announced today the successful completion of its Series A funding round. The company has raised $5 million in funding from 3B Future Health Fund I &amp; II, a venture capital and private equity principal. Geneos Therapeutics, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":3734,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies. - Founder Lodge Latest News<\/title>\n<meta name=\"description\" content=\"Plymouth Meeting, PA - Geneos Therapeutics, a leading biotechnology research company focused on developing personalized immunotherapies for cancer\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies. - Founder Lodge Latest News\" \/>\n<meta property=\"og:description\" content=\"Plymouth Meeting, PA - Geneos Therapeutics, a leading biotechnology research company focused on developing personalized immunotherapies for cancer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-14T13:43:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-14T13:43:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-115.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1553\" \/>\n\t<meta property=\"og:image:height\" content=\"780\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ucheezuma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ucheezuma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/\"},\"author\":{\"name\":\"ucheezuma\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\"},\"headline\":\"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies.\",\"datePublished\":\"2023-04-14T13:43:34+00:00\",\"dateModified\":\"2023-04-14T13:43:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/\"},\"wordCount\":208,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/\",\"name\":\"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies. - Founder Lodge Latest News\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-04-14T13:43:34+00:00\",\"dateModified\":\"2023-04-14T13:43:36+00:00\",\"description\":\"Plymouth Meeting, PA - Geneos Therapeutics, a leading biotechnology research company focused on developing personalized immunotherapies for cancer\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\",\"name\":\"ucheezuma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"caption\":\"ucheezuma\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies. - Founder Lodge Latest News","description":"Plymouth Meeting, PA - Geneos Therapeutics, a leading biotechnology research company focused on developing personalized immunotherapies for cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/","og_locale":"en_US","og_type":"article","og_title":"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies. - Founder Lodge Latest News","og_description":"Plymouth Meeting, PA - Geneos Therapeutics, a leading biotechnology research company focused on developing personalized immunotherapies for cancer","og_url":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-04-14T13:43:34+00:00","article_modified_time":"2023-04-14T13:43:36+00:00","og_image":[{"width":1553,"height":780,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-115.png","type":"image\/png"}],"author":"ucheezuma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ucheezuma","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/"},"author":{"name":"ucheezuma","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3"},"headline":"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies.","datePublished":"2023-04-14T13:43:34+00:00","dateModified":"2023-04-14T13:43:36+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/"},"wordCount":208,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/","url":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/","name":"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies. - Founder Lodge Latest News","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-04-14T13:43:34+00:00","dateModified":"2023-04-14T13:43:36+00:00","description":"Plymouth Meeting, PA - Geneos Therapeutics, a leading biotechnology research company focused on developing personalized immunotherapies for cancer","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/geneos-therapeutics-raises-5-million-in-series-a-funding-from-3b-future-health-fund-i-ii-to-advance-personalized-cancer-immunotherapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Geneos Therapeutics Raises $5 Million in Series A Funding from 3B Future Health Fund I &amp; II to Advance Personalized Cancer Immunotherapies."}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3","name":"ucheezuma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","caption":"ucheezuma"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/3729"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=3729"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/3729\/revisions"}],"predecessor-version":[{"id":3735,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/3729\/revisions\/3735"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/3734"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=3729"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=3729"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=3729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}